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Hypoxia is a common feature of human tumours (Moulder and
Rockwell, 1984) and is increasingly recognized to have an impor-
tant role in determining not only response to therapy (Höckel et al,
1996; Fyles et al, 1998a) but also tumour progression (Brown and
Giaccia, 1998). Hypoxia provides a physiological pressure on
tumour cells and has been shown to induce apoptosis via p53, in
those cells with intact apoptotic machinery (Graeber et al, 1994,
1996; Kim et al, 1997). Apoptosis has also been found to co-
localize with hypoxic regions in p53-positive mouse tumours
(Graeber et al, 1996). However, hypoxia influences tumours in
paradoxically opposing ways: it is lethal to cells but prolonged
exposure can also have a protective effect, via the selection of cells
with reduced apoptotic ability (Graeber et al, 1996). The latter can
lead to therapy-resistant hypoxic areas that can act as a focus for
tumour regrowth.
Changes in tumour oxygenation during radiotherapy were
initially demonstrated by Badib and Webster (1969) in a mixture
of carcinomas and lymphomas and have since been demonstrated
in clinical studies of the cervix and head and neck (Fyles et al,
1998b; Lartigau et al, 1998; Stadler et al, 1998). Although
pretreatment hypoxia has been shown to be a negative prognostic
indicator (Höckel et al, 1993; Fyles et al, 1998a), the therapeutic
significance of changes in oxygenation post-treatment, in terms of
patient survival, remains unclear. A study by Fyles et al (1998b)
measured oxygenation, with the Eppendorf pO2 histograph,
pretreatment and at the end of external beam radiotherapy, in 43
patients with cervical carcinoma. The second measure of oxygena-
tion was not predictive of patient survival. Also, there was no
difference in the disease-free survival of patients that demon-
strated an improvement in oxygenation versus those that showed a
decrease in oxygenation after external beam radiotherapy. The
mechanisms that facilitate the changes in oxygenation are
unknown, although tumour shrinkage, reduced interstitial pressure
and decreased oxygen metabolism have been suggested. An
understanding of the mechanisms might lead to methods for
controlling/manipulating tumour hypoxia and changes in oxygena-
tion, in an attempt to enhance tumour curability.
Although the relationship between hypoxia and apoptosis has
been investigated using human tumour cell lines in vitro and
animal models, no work has been carried out in human tumours. It
has been suggested that clinically hypoxia, a negative prognostic
indicator, is more of a problem in squamous cell carcinoma (SCC)
than adenocarcinoma (Overgaard and Horsman, 1997). Apoptosis
has also been shown to be a negative prognostic indicator in SCC
of the cervix (Levine et al, 1995). This led to the hypothesis that
pretreatment apoptosis may reflect the level of tumour hypoxia in
SCC (Sheridan et al, 1999). Therefore, the aims of this study were
to examine the relationships between apoptosis, hypoxia and
changes in the level of oxygenation post 40–45 Gy external beam
radiotherapy, in patients with SCC of the cervix.
Pretreatment apoptosis in carcinoma of the cervix
correlates with changes in tumour oxygenation during
radiotherapy
MT Sheridan1, CML West1, RA Cooper1, IJ Stratford3, JP Logue3, SE Davidson2 and RD Hunter2
1CRC Department of Experimental Radiation Oncology, Paterson Institute for Cancer Research and 2Department of Clinical Oncology, Christie Hospital NHS
Trust, Manchester M20 4BX, UK; 3School of Pharmacy and Pharmaceutical Sciences, The University of Manchester, Oxford Road, Manchester M13 9PL, UK
Summary A relationship between hypoxia and apoptosis has been identified in vitro and in experimental tumours. The aim of this study was
to investigate the relationship between apoptosis, hypoxia and the change in oxygenation during radiotherapy in human squamous cell
carcinoma of the cervix. Forty-two patients with locally advanced disease underwent pretreatment evaluation of tumour oxygenation using an
Eppendorf computerized microneedle electrode. Twenty-two of these patients also had a second evaluation of tumour oxygenation after
receiving 40–45 Gy external beam radiotherapy. Paraffin-embedded histological sections were obtained from random pretreatment biopsies
for all 42 patients. Apoptotic index (AI) was quantified by morphology on TUNEL stained sections. No correlation was found between
pretreatment measures of AI and either the median pO2 (r = 0.12, P = 0.44) or percentage of values < 5 mmHg (r = –0.02, P = 0.89). A
significant positive correlation was found between AI and the change in tumour oxygenation (ratio of pre:post-treatment % values < 5 mmHg)
following radiotherapy (r = 0.61, P = 0.002). The lack of correlation between apoptosis and hypoxia may occur because the Eppendorf
measures both acute and chronic hypoxia, and the relative ability of acute hypoxia to induce apoptosis is unknown. These results indicate that
cell death via apoptosis may be a mechanism of tumour reoxygenation during radiotherapy. © 2000 Cancer Research Campaign
Keywords: cervix carcinoma; apoptosis; hypoxia; reoxygenation; radiotherapy
1177
Received 18 June 1999
Revised 12 October 1999
Accepted 12 October 1999
Correspondence to: CML West
British Journal of Cancer (2000) 82(6), 1177–1182
© 2000 Cancer Research Campaign
Article no. bjoc.1999.1059, available online at http://www.idealibrary.com on MATERIALS AND METHODS
Patients
Between May 1996 and July 1997, 42 patients with locally
advanced SCC of the cervix underwent pretreatment evaluation of
tumour oxygenation using a pO2 histograph (Model KIMOC-
6650, Eppendorf, Hamburg, Germany). Twenty-two of these
patients also underwent a second evaluation of tumour oxygena-
tion, following external beam radiation to a dose of 40–45 Gy.
Patients were eligible if they had tumours greater than 2 cm in
diameter and were to undergo routine examination under anaes-
thetic as part of the staging process. Tumour size was assessed
clinically, radiologically (MRI) or both. Tumour shrinkage was
calculated using the clinically assessed pre- and post-treatment
tumour size. Patients were staged according to the FIGO system.
The study had full ethical approval and all patients gave prior
informed consent. Patients were treated with radical radiotherapy
as described elsewhere (Levine et al, 1995). There were three
patients with stage Ib, 15 with stage IIb, 23 with stage IIIb and 1
with stage IVb disease. All patients had SCC. The mean age of the
patients was 58 years (range 28–79 years).
Measurement of tumour oxygenation
Tumour oxygenation measurements were performed using a
sterile polarographic needle electrode (Eppendorf), prior to treat-
ment in patients with primary tumours > 2 cm in diameter and post
40–45 Gy radiotherapy, in patients with clinically residual disease
> 1 cm in diameter. The first measurement was taken a median of
9 days prior to the start of external beam radiotherapy (range 1–18
days) and the second, a median of 7 days post-treatment (range 4 h
to 13 days), at the time of the brachytherapy insertion. Patients
were anaesthetized with propofol infusion. Technical details of the
Eppendorf have been described elsewhere (Vaupel et al, 1991).
Measurement tracks were performed at the 12 and 6 o’clock posi-
tions as described previously (Cooper et al, 1999). The median
number of tumour tracks evaluated was 4 (range 2–7) and the
median number of measurements recorded was 184 (range
70–255) per patient. The median pO2 and hypoxic fraction were
calculated. For the purpose of this study, the ‘hypoxic fraction’ is
defined as the percentage of values less than 5 mmHg (% values 
< 5 mmHg). The latter was selected prior to analysis, as it is the
most commonly used parameter.
Measurement of apoptosis
Apoptosis was measured in coded paraffin-embedded histological
sections of tumour biopsy material, which was taken from random
areas of the tumour, at the time of the first oxygenation measure-
ment. The TUNEL assay was carried out on tumour sections using
an Apoptag kit (Oncor, Gaithersburg, MD, USA), according to the
manufacturer’s instructions. Apoptosis was quantified as TUNEL-
positive cells and cells with apoptotic morphology (even if
TUNEL-negative). This method of quantifying apoptosis in histo-
logical sections has been shown to be reliable and specific
(Sheridan et al, 1999).
TUNEL assay
Tissue sections were deparaffinized using xylene, followed 
by rehydration in ethanol–water baths of descending ethanol
concentrations. Nuclei of tissue sections were stripped of proteins
by incubation with 20 mg ml–1 proteinase K (Sigma) for 15 min at
room temperature, after which the slides were washed in four
changes of distilled water for 2 min each wash. Endogenous
peroxidase activity was quenched by covering the sections with
3% hydrogen peroxide for 5 min at room temperature. The
sections were then rinsed twice with phosphate-buffered saline
(PBS), pH 7.4, for 5 min each time. Equilibration buffer was
applied directly onto the slide and incubated at room temperature
for 10–15 s, after which the excess liquid was removed. Working
strength terminal deoxynucleotidyl transferase (TdT) was added
directly to the sections and incubated in a humidified chamber at
37°C for 60 min. The reaction was terminated by transferring the
slides to a Stop/Wash buffer for 10 min at room temperature. The
slides were washed in three changes of PBS for 5 min each wash.
Anti-digoxigenin-peroxidase was added directly to the slides,
which were then incubated in a humidified chamber for 30 min at
room temperature. Colour development was carried out using a
3,3¢-Diaminobenzidine (DAB) substrate working solution.
Sections were counterstained in methyl green for 4 min at room
temperature.
Quantification of AI
A cell was considered to have an apoptotic morphology if any
three of the following morphological features were evident: cell
shrinkage, loss of contact with neighbouring cells, chromatin
condensation, margination of the chromatin, blebbing. Apoptosis
affects scattered single cells not groups of adjoining cells, as is the
case with necrosis (Kerr et al, 1972). Since the TUNEL assay also
identifies necrotic cells (Grasl-Kraupp et al, 1995), those areas 
of a section which were populated with > 10 adjacent TUNEL or
morphologically positive cells were avoided, as these were consid-
ered to correspond with necrotic areas. A total of 2000 cells per
section were scored and the AI expressed as the percentage of cells
with an apoptotic morphology and/or TUNEL positivity. The same
observer evaluated reproducibility of scoring AI by making two
independent scores (separated by a week), on the first ten tumour
sections.
Measurement of proliferation
The mitotic index (MI) was evaluated in each TUNEL-stained
tumour section. A total of 2000 cells per section were scored and
the MI expressed as the percentage of cells displaying a mitotic
figure.
Statistical analysis
The relationships between the parameters were assessed using
Spearman’s non-parametric correlation coefficient (r). All tests of
statistical significance were two-sided.
RESULTS
AI and MI was quantified in formalin-fixed, paraffin-embedded
histological sections for all 42 patients. The median AI was 3.45%
(range 1.10–8.30%, Table 1), while the median MI was 0.68%
(range 0–2.25%). No correlation was found between the MI and
AI (r = 0.03, P = 0.83), MI and measures of oxygenation (hypoxic
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during radiotherapy (r = 0.09, P = 0.70). Reproducibility of
scoring apoptosis was demonstrated by the significant correlation
between the two estimates of AI, scored independently on coded
slides (with an interval of 1 week), by the same observer on the
same ten sections (r = 0.70, P = 0.03).
Hypoxia and apoptosis
Pretreatment oxygenation measures were obtained for 42 patients
(Table 1). The median of the hypoxic fraction (% values < 5
mmHg) and the median pO2 (mmHg) values were 55% (range
1–95%) and 4 mmHg (range 0–45 mmHg). No correlation was
found between AI and pretreatment oxygenation expressed as
either the median pO2 (mmHg) or the % values < 5 mmHg
(Figures 1 and 2).
Change in post-radiotherapy tumour oxygenation and
apoptosis
Of the 42 patients, 22 underwent a second post-treatment measure
of oxygenation. For the remaining 20 it was not possible to make a
second measure due to technical difficulties (n = 12) or tumour
regression (n = 8). There was a significant difference between the
mean pre- and post-treatment hypoxic fractions for the 22 patients
(57% vs 42%, P = 0.02) and median pO2 values (9 mmHg vs 
20 mmHg, P = 0.01). A ratio of pre- to post-treatment % values 
< 5 mmHg, was used to calculate the fold increase in oxygenation
after 40–45 Gy radiotherapy (median = 1.51, range 0.39–3.80).
The ratio increased with increasing tumour oxygenation post-
radiotherapy, i.e. decreasing hypoxic fraction. There was no corre-
lation between the time of the second measure of oxygenation after
completion of external beam radiotherapy and the change in
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Table 1 Apoptosis (AI) and oxygenation (pO2 mmHg) measurements obtained from 42 SCC cervix patients. A second post-treatment oxygenation
measurement was obtained for 22 patients
Patient Stage Age Grade AI Pretreatment Post-treatment Fold decrease in
(years) Median Hypoxic Median Hypoxic hypoxic fractionb
pO2 mmHg fractiona pO2 mmHg fraction
1 IIb 28 Poor 3.60 0 84 2 65 1.29
2 IIb 44 Poor 2.00 2 60 6 46 1.30
3 IIIb 54 Mod 1.90 21 31 3 58 0.53
4 IIIb 49 Poor 5.05 0 95 46 25 3.8
5 IIb 76 Mod 2.30 1 87
6 IIIb 34 Mod 2.75 6 50
7 IIb 57 Mod 2.05 1 92
8 IIIb 58 Well 4.10 2 91 21 39 2.33
9 IIIb 62 Mod 8.30 31 23 55 8 2.88
10 IIIb 65 Mod 1.50 8 30
11 IIIb 77 Mod 6.25 1 72 11 23 3.13
12 IIIb 71 Poor 5.20 17 43 22 37 1.16
13 IIIb 75 Poor 4.05 4 55 20 22 2.50
14 IIIb 66 Mod 3.25 1 61 18 38 1.61
15 IIIb 69 Well 4.65 4 56
16 IVb 41 Poor 4.55 3 78 3 86 0.91
17 IIIb 42 Mod 2.15 2 58 1 93 0.62
18 IIIb 67 Mod 2.79 33 19
19 IIb 60 Well 1.40 1 78
20 IIb 42 Mod 2.50 3 55 61 19 2.89
21 IIb 49 Mod 4.10 7 46
22 IIb 77 Poor 2.30 1 82
23 IIIb 73 Mod 2.65 25 41
24 IVb 73 Poor 1.45 2 54
25 IIb 49 Mod 4.40 2 60 21 24 2.50
26 IIb 77 Mod 5.65 5 47
27 IIIb 54 Mod 4.40 3 88 3 60 1.47
28 IIb 29 Mod 2.60 22 30 58 22 1.36
29 IIb 79 Mod 4.65 1 72
30 Ib 65 Well 3.65 5 49
31 IIIb 58 Mod 1.65 14 31 1 79 0.39
32 IIb 60 Mod 1.65 20 34 18 43 0.79
33 IIb 48 Mod 4.40 45 29
34 IIIb 68 Mod 1.10 1 76
35 Ib 43 Mod 5.05 4 50 11 32 1.56
36 IIIb 54 Mod 3.30 4 59 22 32 1.84
37 Ib 72 Mod 1.15 19 1
38 IIIb 38 Poor 2.05 0 79 3 70 1.13
39 IIIb 55 Mod 3.60 1 55
40 IIIb 40 Mod 5.35 38 23 24 13 1.77
41 IIb 55 Poor 4.15 8 2
42 IIIb 78 Poor 4.75 13 38
AI – apoptotic index, pO2 – partial pressure of oxygen measured using Eppendorf histography system. aHypoxic fraction – % values < 5 mmHg. bFold
decrease in hypoxic fraction – ratio of pre:post-treatment hypoxic fractions.oxygenation (r = 0.11, P = 0.59). Figure 3 illustrates the significant
positive correlation between AI and the change in oxygenation
post external beam radiotherapy (r = 0.61, P = 0.002). This corre-
lation remained, albeit with less significance, when cut-off points
of 2.5 (r = 0.48, P = 0.023) and 10 mmHg (r = 0.50, P = 0.019)
were used to calculate the hypoxic fraction. Finally, those tumours
that had an increased level of oxygenation post-treatment, had
significantly higher levels of pretreatment apoptosis than those
tumours that remained unchanged or decreased in oxygenation 
(P = 0.02, Table 2). The correlation was lost, however if the
median pO2 value was used to calculate the change in oxygenation 
(r = –0.16, P = 0.59).
DISCUSSION
Hypoxia and apoptosis
Clinical studies investigating the importance of hypoxia, in rela-
tion to tumour response to therapy and prognosis, have used 
the Eppendorf histograph system (Lyng et al, 1997, Fyles et al,
1998a). In this study hypoxia was also measured using this system
and expressed as median pO2 mmHg and % values < 5 mmHg.
The median and range of median pO2 values and % values 
> 5 mmHg, were similar to those found by other investigators
using the Eppendorf histograph system to measure oxygenation in
cervical tumours (Lyng et al, 1997; Fyles et al, 1998a).
Tumour hypoxia can occur in two ways: diffusion-limited or
chronic hypoxia and by the temporary obstruction or cessation of
tumour blood flow – acute or intermittent hypoxia (Brown and
Giaccia, 1998). The Eppendorf system, however, cannot differen-
tiate between the two origins of hypoxia but measures actual
oxygenation status in an area of tumour, which may contain
necrotic, oxygenated or hypoxic cells. In vitro studies have exam-
ined the induction of apoptosis under chronic hypoxia (24–48 h)
1180 MT Sheridan et al
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Figure 1 The lack of relationship between AI and median pO2 (mmHg) for
42 patients with SCC of the cervix. Apoptosis was measured in TUNEL-
stained histological sections and quantified as TUNEL-positive cells in
combination with morphology. pO2 was measured in patients prior to
treatment using an Eppendorf pO2 histograph
Figure 3 The relationship between the level of apoptosis and the change in
tumour oxygenation post external beam radiation, in 22 patients with SCC of
the cervix. Apoptosis was measured in TUNEL-stained histological sections.
The ratio of pre- to post-treatment hypoxic fraction was used to calculate the
fold decrease in tumour hypoxic fraction
Figure 2 The lack of relationship between AI and hypoxic fraction in 42
patients with SSC of the cervix. Apoptosis was measured in TUNEL-stained
histological sections and quantified as TUNEL-positive cells in combination
with morphology. The hypoxic fraction was calculated as the % pO2 values
less than 5 mmHg. A median of 175 measurements was recorded for each
patient
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Table 2 Differences in AI between tumours that showed (1) a decrease in
oxygenation post 40–45 Gy, (2) an increase in oxygenation or (3) complete
tumour regression
Post-treatment AI (%) P
Mean ± s.e.m.
Oxygenation Œ (n = 5) 2.38 ± 0.55
Oxygenation Ø (n = 16) 4.20 ± 0.39 0.02
Tumour regressed (n = 8) 3.40 ± 0.53 0.19and found a relationship between hypoxia and apoptosis induction
(Graeber et al, 1996; Kim et al, 1997). An in vivo murine tumour
study also showed that apoptotic cells co-localized with hypoxic
regions, detected by the hypoxia marker EF5 (Graeber et al, 1996).
There are no reports, however, on the induction of apoptosis under
repeated acute hypoxia. In the work reported here no relationship
was seen between apoptosis and tumour hypoxia measured using
the Eppendorf histograph. However, due to the limitations of the
current technology, it may be difficult to establish the in vivo rela-
tionship between apoptosis and hypoxia. There may still be a rela-
tionship between apoptosis and chronic hypoxia, that could be
investigated in the future using a histological marker of hypoxia
alone, e.g. pimonidazole.
Another explanation for the lack of relationship between
hypoxia and apoptosis in this study is the possible confounding
influence of p53, or accumulated genetic alterations, on the apop-
totic sensitivity of tumours to hypoxia. A study by Graeber et al
(1996) investigated the relationship between hypoxic and apop-
totic regions in tumours derived from E1A- and Ha-ras-trans-
formed p53+/+ and p53–/– cells and showed the importance of p53
status in influencing this relationship. Apoptotic regions were
more prevalent in p53+/+ than p53–/– tumours. In cervical cancer the
presence of the human papillomavirus (HPV) E6 gene promotes
ubiquitin-dependent degradation of wild-type p53 and results in
the loss of apoptotic sensitivity to genotoxic stress such as ionizing
radiation. However, it has been shown in normal epithelial cells
transfected with HPV E6 and E7 that hypoxia can uncouple p53
from E6-mediated ubiquitin degradation and render the apoptotic
pathway functional (Kim et al, 1997). These investigations into 
the relationship between hypoxia, apoptosis and HPV have been
carried under controlled conditions using cell lines and murine
tumours. In contrast, the study described here used human tumour
biopsy material which, as well as having lost p53 function through
HPV infection, may also have accumulated additional genetic
alterations. This might result in loss of apoptotic sensitivity to
hypoxia through a p53-independent pathway (Kim et al, 1997).
Change in post-radiotherapy tumour oxygenation and
apoptosis
A study of changes in tumour oxygenation during radiotherapy is
described in detail elsewhere (Cooper et al, 1999). Overall, tumour
oxygenation increased following 40–45 Gy external beam radio-
therapy. For the 22 patients that had a second measure of oxygena-
tion, the median pO2 value increased from 3 mmHg to 18 mmHg
and the median hypoxic fraction decreased from 59% to 38%. This
change in oxygenation post-radiotherapy is similar to that seen by
Lartigau et al (1998), in a study of tumour oxygenation in 14
patients with head and neck cancer. In that work, the median pO2
increased after 32 Gy (2 weeks) from 12 mmHg to 26 mmHg.
However, Fyles et al (1998b) investigated the oxygenation levels
in 43 patients with cervical carcinoma, following a median dose of
50 Gy and found no significant differences between the pre- and
post-treatment values. The median pO2 remained at 12 mmHg and
the hypoxic fraction increased post-treatment from 37% to 41%.
In this study, we have shown a significant positive relationship
between the level of change in oxygenation post-radiotherapy and
the AI (Figure 3). That is, those patients with a high level of
pretreatment apoptosis had increased levels of post-treatment
oxygenation. Although this increase in tumour oxygenation during
radiotherapy measured by the Eppendorf histograph is not the
same as radiobiological reoxygenation, the mechanisms involved
may be similar. These have been suggested to include: reduced O2
metabolism, improved circulation, tumour shrinkage, migration of
surviving cells from formerly hypoxic areas into areas of more
adequate oxygenation (Horsman and Overgaard, 1997).
Our results suggest that cell death by apoptosis may be facili-
tating reoxygenation in SCC of the cervix. To support this argu-
ment, needle track biopsies, which were taken from the region of
the tumour where oxygen measurements had been performed,
were examined for apoptosis after radiotherapy (n = 9). Due to
limited or a lack of viable tumour in these post-radiotherapy
biopsies it was not possible to quantify the level of apoptosis.
However, in the biopsies from patients who showed an increase in
oxygenation after radiotherapy (n = 6), it was observed that there
was either no tumour cells (n = 5) or extensive apoptosis in those
that remained (n = 1). Biopsies from patients whose tumours did
not show an increase in oxygenation (n = 3), had very low levels of
apoptosis (< 1%, n = 2) and viable tumour cells, while in one case
no tumour was evident.
Tumour shrinkage as a result of apoptosis has previously been
identified in animal models (Meyn et al, 1992, 1993; Milas et al,
1995; Rupnow et al, 1998). Tumour shrinkage would relieve pres-
sure on blood vessels and reduce the level of intermittent hypoxia.
Indeed, the study by Milas et al (1995) showed that elimination 
of tumour cells by apoptosis resulted in tumour reoxygenation,
measured by the Eppendorf histograph, and subsequently
confirmed as radiobiological reoxygenation. In the study presented
here, however, no relationship was found between tumour
shrinkage, measured clinically and the level of pretreatment apop-
tosis (n = 22, r = –0.32, P = 0.15) or the change in oxygenation
during radiotherapy (n = 22, r = –0.15, P = 0.45). That is, those
tumours that reduced in size did not necessarily display an increase
in oxygenation post-treatment. However, a reduction in interstitial
fluid pressure (IFP) can also lead to increased tumour oxygena-
tion, independent of size (Milosevic et al, 1998). Therefore, it is
hypothesized that the change in oxygenation observed in this study
may be due to reduced IFP as a result of cell loss via apoptosis.
The cell loss would relieve pressure on vessels, increasing tumour
blood flow and thus oxygen delivery, without affecting tumour
size. Further investigations are required to test this hypothesis.
Clinical implications
Two studies of adenocarcinoma of the cervix have shown a corre-
lation between high levels of pretreatment apoptosis and a good
prognosis (Wheeler et al, 1995; Sheridan et al, 1999). In contrast,
two studies of predominantly SCC of the cervix showed that high
apoptosis predicted for a poor prognosis (Levine et al, 1995; Tsang
et al, 1999). These studies used similar methods for measuring
apoptosis and had comparable radiotherapy treatment regimes. We
hypothesized previously that the conflicting results are due to a
higher incidence of hypoxia in SCC versus adenocarcinoma
(Sheridan et al, 1999), and that in SCC there may be an association
between hypoxia and apoptosis. The results reported here,
however, using an Eppendorf pO2 histograph, showed no relation-
ship between hypoxia and apoptosis. Nevertheless, a relationship
was found between apoptosis and reoxygenation – an event tradi-
tionally thought to be a positive factor during radiotherapy. As
stated above, however, apoptosis in SCC is also related to a poor
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nutritional replenishment may lead to accelerated repopulation, a
more aggressive tumour and a poor prognosis. A larger number of
patients and longer follow-up are required to investigate the rela-
tionship between re-oxygenation and patient survival.
Finally, the results presented in this study suggest two possible
clinical implications for the novel treatment of cervical carcinoma,
which aims to manipulate apoptosis through novel gene therapy
approaches. Firstly, in adenocarcinomas, apoptosis has been
shown to relate to improved survival following radiotherapy and
so a therapeutic intervention, which would enhance tumour
apoptosis should be beneficial. Secondly, and in contrast, for SCC,
apoptosis has been show to relate to poor survival (Levine et al,
1995) following radiotherapy, and so this would suggest that,
enhancing the level of apoptosis (at least during radiotherapy)
might prove detrimental to the patient.
In conclusion, no relationship was found between apoptosis and
hypoxia. There was, however, a significant positive correlation
between apoptosis and the change in oxygenation after radio-
therapy. This indicates that cell death via apoptosis may facilitate
reoxygenation in SCC of the cervix.
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